According to evidence-based stroke protocols, which antiplatelet regimen is recommended for secondary prevention after a minor ischemic stroke or high-risk TIA (ABCD2 ≥4)?
-
A
Aspirin monotherapy 325 mg daily
-
B
Clopidogrel monotherapy 75 mg daily
-
C
Dual antiplatelet therapy with aspirin and clopidogrel for 21 days
-
D
Warfarin with target INR 2–3